Philip H. Coelho, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 47,532 shares at $5.58 ($264K) on 2021-08-24, disclosed to the SEC on 2021-08-26.
Open-market sale of $264k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.58 | 9,494 | $53K | 20.1% |
| 2 | $5.58 | 9,494 | $53K | 20.1% |
| 3 | $5.56 | 9,498 | $53K | 20.0% |
| 4 | $5.56 | 9,498 | $53K | 20.0% |
| 5 | $5.45 | 9,044 | $49K | 18.7% |
| 6 | $5.46 | 504 |
| $3K |
| 1.0% |
| Total | $5.55 avg | 47,532 | $264K | 100% |
| Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $40K | — | Filing → |